Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry

European Journal of Clinical Pharmacology
C Hiemke

Abstract

Based on the assumption that a relationship between blood levels and clinical effects (therapeutic effects, adverse events and toxicity) can be defined and considering that after equal doses plasma concentrations vary markedly between individual patients, therapeutic drug monitoring (TDM) can assist to personalize dose adjustment. Taken together, drug levels and a knowledge of the pharmacological profile of the administered drugs can enable the optimal dosage to be tailored according to the need of the individual patient. Therapeutic drug monitoring has been established for a limited number of drugs. In psychiatry, it has a 40-year-long history, which started with nortriptyline. Evidence has accumulated which shows that TDM is a valid tool for the optimization of psychopharmacotherapy. When used adequately, TDM is helpful for many patients and in many situations. Combined with pharmacogenetic tests, the metabolic status of a patient can be well characterized. Several new observations have been made during routine TDM that have stimulated clinical pharmacological research, such as investigations on inherited differences in drug metabolism that are closely linked to TDM in psychiatry. The contributions of individual forms of cyto...Continue Reading

References

Jan 1, 1991·Schizophrenia Bulletin·T Van PuttenN Chabert
Jan 1, 1991·European Journal of Clinical Pharmacology·G BertschyR Volmat
Jul 1, 1991·Journal of Psychiatry & Neuroscience : JPN·J M Kellett
Jan 1, 1989·Psychopharmacology·H Hippius
Jul 1, 1989·The American Journal of Psychiatry·A B AranowJ O Cole
Jan 1, 1988·Archives of General Psychiatry·R J BaldessariniM H Teicher
Mar 1, 1970·Archives of General Psychiatry·S H CurryJ H Marshall
Aug 7, 1971·British Medical Journal·M AsbergD Tuck
Aug 1, 1994·Journal of Clinical Psychopharmacology·C HiemkeH Müller
Jul 11, 1998·The American Journal of Psychiatry·S KapurS Houle
May 8, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·S HärtterC Hiemke
Jan 5, 2002·The American Journal of Psychiatry·Christian R DolderDilip V Jeste
Jul 3, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Fuji YokoiDean F Wong
Dec 7, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Peter S Talbot, Marc Laruelle
Dec 14, 2002·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael BauerUNKNOWN World Federation of Societies Biological Psychiatry Task Force on Treatment Guidelines for Unipolar Depressive Disorders
Jul 2, 2004·Therapeutic Drug Monitoring·Finn Bengtsson
Jul 2, 2004·Therapeutic Drug Monitoring·Christoph HiemkeMatthias J Müller
Sep 24, 2004·Therapeutic Drug Monitoring·Gerald ZernigAlois Saria
Nov 20, 2004·Pharmacopsychiatry·P BaumannUNKNOWN Arbeitsge-meinschaft fur neuropsychopharmakologie und pharmakopsychiatrie
Jan 25, 2005·Therapeutic Drug Monitoring·D J TouwUNKNOWN Cost-Effectiveness of Therapeutic Drug Monitoring Committee of the International Association for Therapeutic Drug Monitoring
Feb 3, 2005·The International Journal of Neuropsychopharmacology·Ingo VernalekenGerhard Gründer
Sep 1, 2005·Basic & Clinical Pharmacology & Toxicology·Mirko S FaberUwe Fuhr
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Dec 6, 2005·Journal of Psychiatric Research·Matthias J MüllerChristoph Hiemke
Dec 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rossella MedoriGerhard Gründer
Jun 27, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·H Kirchherr, W N Kühn-Velten
Sep 2, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Eveline Jaquenoud SirotPierre Baumann

❮ Previous
Next ❯

Citations

Jun 29, 2010·European Journal of Clinical Pharmacology·Guillermo GervasiniJuan Antonio Carrillo
Oct 23, 2013·Biosensors & Bioelectronics·C Baj-RossiS Carrara
Jun 22, 2012·Clinical Drug Investigation·Stefan UntereckerBruno Pfuhlmann
Sep 16, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Victor A VoicuDalia Simona Miron
Jul 30, 2015·Acta Clinica Belgica·Innocent HahirwaRaphaël Denooz
Mar 16, 2013·Journal of Gastroenterology and Hepatology·Yunki YauValerie C Wasinger
Jun 24, 2014·IEEE Transactions on Biomedical Circuits and Systems·Sara S GhoreishizadehGiovanni De Micheli
Jun 8, 2012·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Stephen M Rappaport
Nov 5, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louise HerbildDorte Gyrd-Hansen
Mar 3, 2015·European Psychiatry : the Journal of the Association of European Psychiatrists·W GaebelUNKNOWN European Psychiatric Association
Dec 21, 2016·ACS Applied Materials & Interfaces·Deepak JainPhilippe Barthélémy
Nov 2, 2018·Psychiatry Investigation·Can Ilgın, Ahmet Topuzoğlu
Nov 23, 2013·Therapeutic Drug Monitoring·Wei GuoWen-Biao Li
Mar 28, 2020·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Sara BaldelliEmilio Clementi
May 19, 2020·Expert Opinion on Drug Safety·Sanne M KloosterboerBirgit C P Koch
Apr 9, 2020·Frontiers in Pharmacology·Linden Lalley-ChareczkoHelen Koenig
Nov 23, 2011·Therapeutic Drug Monitoring·Stefan UntereckerBruno Pfuhlmann
Aug 25, 2020·Journal of Pharmaceutical Analysis·Sumin BianMohamad Sawan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.